Esophageal Squamous Cell Carcinoma

You have access
[¹⁸F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
Yinjun Dong, Zhendan Wang, Xinying Hu, Yuhong Sun, Jingjie Qin, Qiming Qin, Shuguang Liu, Shuanghu Yuan, Jinming Yu and Yuchun Wei

Journal of Nuclear Medicine November 1, 2024, 65 (11) 1702-1709; DOI: https://doi.org/10.2967/jnumed.124.268557
You have access
Response Prediction Using ¹⁸F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy
Xinying Hu, Tao Zhou, Jiazhong Ren, Jinghao Duan, Hongbo Wu, Xiaoli Liu, Zhengshuai Mu, Ning Liu, Yuchun Wei and Shuanghu Yuan

Journal of Nuclear Medicine April 1, 2023, 64 (4) 625-631; DOI: https://doi.org/10.2967/jnumed.122.264638

Main menu